Latest filing published 10 Nov 2022 for GSK plc, €288.
Insider track record
R Connor: trading record in brief
R Connor discloses dealings in GSK plc to RNS (LSE). We count 7 filings; the first trade dates from 9 August 2022 and the latest from 9 November 2022.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 10 November 2022: a share grant of €288, in GSK plc. Typically, a trade is published a median of 2 days after it takes place. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to R Connor
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 18 shares@ £13.96390.5% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63FCA-NSM:4575678-1
- 517 shares@ £13.22614.7% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63FCA-NSM:4543614-3
- 2,833.461 shares@ £13.571881.7% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63FCA-NSM:4543310-1
- 18 shares@ £13.55390.5% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63FCA-NSM:4543181-1
- 69 shares@ £13.33912.0% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63FCA-NSM:4537632-1
- 18 shares@ £13.62110.5% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63FCA-NSM:4507899-1
- 16 shares@ £16.41310.6% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63FCA-NSM:4471508-1
7 of 7 declarations
